Skip to main content
×
Home

A comparison of clinical outcomes between healthcare-associated infections due to community-associated methicillin-resistant Staphylococcus aureus strains and healthcare-associated methicillin-resistant S. aureus strains

  • S. J. EELLS (a1) (a2) (a3), J. A. McKINNELL (a1) (a2) (a3), A. A. WANG (a1), N. L. GREEN (a4), D. WHANG (a4), P. O'HARA (a5), M. L. BROWN (a5) and L. G. MILLER (a1) (a2) (a3)...
Summary
SUMMARY

There are limited data examining whether outcomes of methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAIs) are worse when caused by community-associated (CA) strains compared to HA strains. We reviewed all patients’ charts at our institution from 1999 to 2009 that had MRSA first isolated only after 72 h of hospitalization (n = 724). Of these, 384 patients had a MRSA-HAI according to CDC criteria. Treatment failure was similar in those infected with a phenotypically CA-MRSA strain compared to a phenotypically HA-MRSA strain (23% vs. 15%, P = 0·10) as was 30-day mortality (16% vs. 19%, P = 0·57). Independent risk factors associated with (P < 0·05) treatment failure were higher Charlson Comorbidity Index, higher APACHE II score, and no anti-MRSA treatment. These factors were also associated with 30-day mortality, as were female gender, older age, MRSA bloodstream infection, MRSA pneumonia, and HIV. Our findings suggest that clinical and host factors, not MRSA strain type, predict treatment failure and death in hospitalized patients with MRSA-HAIs.

Copyright
Corresponding author
*Author for correspondence: L. G. Miller, M. D., M. P. H., Associate Professor of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Harbor-UCLA Medical Center, 1000 W Carson St, Box 466, Torrance CA 90509, USA. (Email: Lgmiller@ucla.edu)
References
Hide All
1.Hidron AI, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control and Hospital Epidemiology 2008; 29: 9961011.
2.McDougal LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. Journal of Clinical Microbiology 2003; 41: 51135120.
3.Seybold U, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clinical Infectious Diseases 2006; 42: 647656.
4.Maree C, et al. Community-associated methicillin-resistant Staphylococcus aureus strains causing healthcare-associated infections. Emerging Infectious Diseases 2007; 13: 236242.
5.Rodriguez-Bano J, et al. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococcus aureus in Spain. Clinical Microbioliology and Infection 2009; 15: 11111118.
6.Gonzalez BE, et al. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infection Control and Hospital Epidemiology 2006; 27: 10511056.
7.Klevens RM, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerging Infectious Diseases 2006; 12: 19911993.
8.Stranden AM, et al. Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital. Infection 2009; 37: 4448.
9.Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 11281132.
10.Okuma K, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. Journal of Clinical Microbiology 2002; 40: 42894294.
11.Moran GJ, et al. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerging Infectious Diseases 2005; 11: 928930.
12.Voyich JM, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? Journal of Infectious Diseases 2006; 194: 17611770.
13.Labandeira-Rey M, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315: 11301133.
14.Davis SL, et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology 2006; 27: 10251031.
15.Wang JT, et al. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains. Journal of Infection 2010; 61: 449457.
16.Kreisel KM, et al. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections? Diagnostic Microbiology and Infectious Disease 2011; 70: 285290.
17.Ganga R, et al. Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center. Journal of Clinical Microbiology 2009; 47: 590595.
18.Kempker RR, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. Journal of Infection 2010; 61: 372381.
19.Hota B, et al. Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia. Clinical Infectious Diseases 2011; 53: 757765.
20.Moore CL, et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. International Journal of Antimicrobial Agents 2009; 34: 148155.
21.Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 17631771.
22.Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008; 36: 309332.
23.Wenzel RP. Perspective: attributable mortality – the promise of better antimicrobial therapy. Journal of Infectious Diseases 1998; 178: 917919.
24.Miller LG, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clinical Infectious Diseases 2007; 44: 471482.
25.Miller LG, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clinical Infectious Diseases 2007; 44: 483492.
26.Yang ES, et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clinical Microbiology and Infection 2010; 16: 425431.
27.Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373383.
28.Knaus WA, et al. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13: 818829.
29.Mellmann A, et al. Based upon repeat pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms. BMC Microbiology 2007; 7: 98.
30.Enright MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 10081015.
31.Goering RV, et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. Journal of Clinical Microbiology 2008; 46: 28422847.
32.Brown ML, et al. Prevalence and sequence variation of Panton-Valentine leukocidin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the United States. Journal of Clinical Microbiology 2012; 50: 8690.
33.Kleinbaum DG, Klein M, Pryor ER. Logistic Regression: a Self-learning Text. (Statistics for Biology and Health). Ebooks Corp., 2002.
34.Robinson JO, et al. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. European Journal of Clinical Microbiology & Infectious Diseases 2009; 28: 353361.
35.Lin CC, et al. Methicillin-resistant Staphylococcus aureus bacteremia in patients with end-stage renal disease in Taiwan: distinguishing between community-associated and healthcare-associated strains. Infection Control and Hospital Epidemiology 2009; 30: 8992.
36.Park SH, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infection Control and Hospital Epidemiology 2009; 30: 146155.
37.Roberts MC, et al. Characterization of methicillin-resistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community. Journal of Applied Microbiology 2011; 110: 15311537.
38.Diep BA, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Annals of Internal Medicine 2008; 148: 249257.
39.Han LL, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. Journal of Clinical Microbiology 2007; 45: 13501352.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 1
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 102 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd November 2017. This data will be updated every 24 hours.